We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Research Article

Measurement of free fraction, total concentration and protein binding for testosterone, triiodothyronine and thyroxine

    Emily Klock

    Albany College of Pharmacy & Health Sciences, Department of Pharmaceutical Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA

    ,
    Michael P Kane

    Albany College of Pharmacy & Health Sciences, Department of Pharmacy Practice, 106 New Scotland Avenue, Albany, NY 12208, USA

    &
    Florin M Musteata

    *Author for correspondence: Tel.: +1 518 694 7883;

    E-mail Address: marcel.musteata@acphs.edu

    Albany College of Pharmacy & Health Sciences, Department of Pharmaceutical Sciences, 106 New Scotland Avenue, Albany, NY 12208, USA

    Published Online:https://doi.org/10.4155/bio-2023-0126

    Aims: Measuring the total and free concentrations of hormones is useful, but the technology to do this simultaneously is lacking. Methods: A new method offers the ability to measure these parameters concurrently for testosterone, thyroxine and triiodothyronine. Results: The free concentrations showed significant correlations with patients’ vital statistics. Overall, 67% of correlations for total concentration showed that the new and classical methods had equal accuracy, or that comprehensive ultrafiltration was more accurate. The protein binding term was found to correlate significantly with the patients’ luteinizing hormone, prostate-specific antigen and height. Conclusion: Comprehensive ultrafiltration for measuring the total concentration, free concentration and protein binding term uses less sample and is much faster than measuring these parameters with three separate methods.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Cibotaru D, Celestin MN, Kane MP, Musteata FM. Method for simultaneous determination of free concentration, total concentration, and plasma binding capacity in clinical samples. J. Pharm. Sci. 110(3), 1401–1411 (2021). •• Describes two sample preparation approaches and two calculation approaches for simultaneous measurement of free and total concentrations in the same sample; further describes how to measure both concentrations with and without using isotopically labeled analytes.
    • 2. Summerfield SG, Fairman DA. Free drug theory – no longer just a hypothesis? Pharm. Res. 39(2), 213–222 (2022). •• Recent analysis of the importance of measuring free drug concentrations; points out that the importance of free concentrations is not a hypothesis anymore, but has been proven.
    • 3. Bikle DD. The free hormone hypothesis: when, why, and how to measure the free hormone levels to assess vitamin D, thyroid, sex hormone, and cortisol status. JBMR Plus 5(1), e10418 (2021). • Thorough discussion of the importance of measuring free hormone concentrations.
    • 4. Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr. Rev. 38(4), 302–324 (2017).
    • 5. Illamola SM, Hirt D, Tréluyer JM, Urien S, Benaboud S. Challenges regarding analysis of unbound fraction of highly bound protein antiretroviral drugs in several biological matrices: lack of harmonisation and guidelines. Drug Discov. Today 20(4), 466–474 (2015). • Comprehensive overview of challenges and approaches for monitoring free concentrations.
    • 6. Tanoue R, Kume I, Yamamoto Y et al. Determination of free thyroid hormones in animal serum/plasma using ultrafiltration in combination with ultra-fast liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1539, 30–40 (2018).
    • 7. Thienpont LM, Van Uytfanghe K, Poppe K, Velkeniers B. Determination of free thyroid hormones. Best Pract. Res. Clin. Endocrinol. Metab. 27(5), 689–700 (2013).
    • 8. Kurniawan AL, Hsu CY, Chao JC et al. Association of testosterone-related dietary pattern with testicular function among adult men: a cross-sectional health screening study in Taiwan. Nutrients 13(1), 259 (2021).
    • 9. Page ST, Mohr BA, Link CL, O’Donnell AB, Bremner WJ, McKinlay JB. Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study. Asian J. Androl. 10(2), 193–200 (2008).
    • 10. Reinhardt W, Mülling N, Behrendt S et al. Association between albuminuria and thyroid function in patients with chronic kidney disease. Endocrine 73(2), 367–373 (2021).
    • 11. Alwani M, Al-Zoubi RM, Al-Qudimat A et al. The impact of long-term testosterone therapy (TTh) in renal function (RF) among hypogonadal men: an observational cohort study. Ann. Med. Surg. 69, 102748 (2021).
    • 12. Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J. Mol. Endocrinol. 43(1), 19–27 (2009).
    • 13. Dumoulin SC, Perret BP, Bennet AP, Caron PJ. Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans. Eur. J. Endocrinol. 132(5), 594–598 (1995).
    • 14. Rudorff KH. [Thyroxine-binding globulin (TBG). Clinical studies on the regulation of TBG concentration in serum and the value of TBG for the evaluation of thyroid function]. Fortschr. Med. 97(44), 2038–2045 (1979).
    • 15. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc. Med. J. 5, 76–84 (2011).
    • 16. Kabodmehri R, Sharami SH, Sorouri ZZ et al. The relationship between thyroid function and ovarian reserve: a prospective cross-sectional study. Thyroid Res. 14(1), 22 (2021).
    • 17. Romano RM, Bargi-Souza P, Brunetto EL et al. Triiodothyronine differentially modulates the LH and FSH synthesis and secretion in male rats. Endocrine 59(1), 191–202 (2018).
    • 18. Viguié C, Battaglia DF, Krasa HB, Thrun LA, Karsch FJ. Thyroid hormones act primarily within the brain to promote the seasonal inhibition of luteinizing hormone secretion in the ewe. Endocrinology 140(3), 1111–1117 (1999).
    • 19. Ashok T, Palyam V, Azam AT et al. Relationship between vitamin D and thyroid: an enigma. Cureus 14(1), e21069 (2022).
    • 20. Aboelnaga MM, Abdullah N. The correlation between 25-hydroxyvitamin D levels and testosterone levels in type 2 diabetic male patients. Endocr. Metab. Immune Disord. Drug Targets doi:10.2174/1871530322666220524104929 (2022) (Epub ahead of print).
    • 21. Henderson CM, Fink SL, Bassyouni H et al. Vitamin D-binding protein deficiency and homozygous deletion of the GC gene. N. Engl. J. Med. 380(12), 1150–1157 (2019).
    • 22. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S. Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res. Clin. Pract. 84(2), 163–167 (2009).
    • 23. Cetinkaya E, Aslan A, Vidinlisan S, Ocal G. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr. Int. 45(5), 534–537 (2003).
    • 24. Srivastava S, Rajput J, Shrivastava M, Chandra R, Gupta M, Sharma R. Correlation of thyroid hormone profile with biochemical markers of renal function in patients with undialyzed chronic kidney disease. Indian J. Endocrinol. Metab. 22(3), 316–320 (2018).
    • 25. Kotwal A, Cortes T, Genere N et al. Treatment of thyroid dysfunction and serum lipids: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 105(12), dgaa672 (2020).
    • 26. Cakir E, Sahin M, Topaloglu O et al. The relationship between LH and thyroid volume in patients with PCOS. J. Ovarian Res. 5(1), 43 (2012).
    • 27. Larsen PR. Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J. Clin. Invest. 51(5), 1125–1134 (1972).